IP Library › Patent Application 62207830
Patent Application Provisional
App. No. 62/207,830 · Confirmation No. 1096

ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE

Applicant: Stemcentrx, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2015-10-01 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2015-10-01 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2015-09-27 PA.. Power of Attorney 2 View
2015-09-27 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2015-09-27 N417 Electronic Filing System Acknowledgment Receipt 2 View
2015-09-11 APP.FILE.REC Filing Receipt 3 View
2015-08-24 CRFE Sequence Listing in Computer Readable Format, No errors found 15 View
2015-08-20 SPEC Specification 135 View
2015-08-20 CLM Claims 2 View
2015-08-20 ABST Abstract 1 View
2015-08-20 DRW Drawings-only black and white line drawings 24 View
2015-08-20 ADS Application Data Sheet 6 View
2015-08-20 TR.PROV Provisional Cover Sheet (SB16) 4 View
2015-08-20 WFEE Fee Worksheet (SB06) 2 View
2015-08-20 N417 Electronic Filing System Acknowledgment Receipt 3 View
2015-08-20 SEQ.TXT Sequence Listing (Text File) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/207,830
Filed
2015-08-20